Pinned
It’s a pleasure to announce the appointment of Dr. @AmarUKishan to Executive Vice Chair for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center.
Amar Kishan
3,477 posts
Amar Kishan
@AmarUKishan
Radiation Oncologist, Professor, and Executive Vice Chair of Radiation Oncology at UCLA. All views are my own.
Joined November 2017
- Proud to share that I have been promoted to Professor! An achievement made possible only by working with exceptional colleagues, residents, and students at an exceptional place! @MSteinbergMD @UCLAJCCC @Ucla
- Pleased to share the primary endpoint results of the randomized phase III MIRAGE trial evaluating whether aggressive margin reduction with MRI-guidance leads to reduced toxicity in the context of prostate SBRT, out today in @JAMAOncology jamanetwork.com/journals/jamao… (1/n)
- Pleased to share the results of our "MASTER" systematic review and meta-analysis of local salvage therapies for radioreccurent PCa @EUPlatinum europeanurology.com/article/S0302-…
- bit.ly/33kuBmA Interim results of the MIRAGE randomized trial of MRI-guided vs. CT-guided SBRT to be presented at #GU22 @ASCO, suggesting significantly reduced acute GU≥2 and GI≥2 toxicity with MRI-guidance. @UCLAJCCC
- Detailed topographic analysis of PSMA-defined recurrences after RP in 226 men suggests a majority of recurrences occur inferiorly and posteriorly. Potentially major implications for post-operative RT contouring.Detailed PSMA PET mapping of prostatic bed recurrence patterns provides important information for a redefinition of radiotherapy contouring guidelines. ow.ly/1sGw50MZ4c2 #NuclearMedicine #ProstateCancer @AmarUKishan @a_dalpra @CalaisJeremie @MinsongUC @Matthias_R_Benz
- Very pleased to present the 4th MARCAP analysis, "SANDSTORM" now live online at ascopubs.org/doi/full/10.12… @JCO_ASCO (1/n)
00:00- Very proud to receive this award from @dgsomucla! Kind thanks to my patients, medical students, residents, and colleagues at @UCLAJCCCProud to share that our #uclaradonc Dr. @AmarUKishan is the 2021 recipient of the prestigious Leonard Tow Humanism in Medicine Award. The award recognizes faculty members who demonstrate clinical excellence & outstanding compassion in the delivery of care.
- Very pleased to announce that the LUNAR trial is now open @UCLAJCCC clinicaltrials.gov/ct2/show/NCT05…. SBRT alone vs. 177Lu-PSMA x 2 + SBRT for oligorecurrent hormone-sensitive prostate cancer!
- Happy to share the latest work from the MARCAP consortium, led by outstanding PGY-5 @UCLAJCCC resident @MartinMaMDPhD -- the LEVIATHAN analysis in @EUplatinum
- Replying to @PottersMDI’m disappointed to see this. My disclosures are very upfront. Regardless, this seems to be an attack on my ethics. I ran a randomized trial, which was not funded by industry, and simply am reporting the results. Do my disclosed conflicts of interest impact the findings?
- @MartinMaMDPhD @UCLAJCCC Early results of our phase II trial of SBRT to the prostate fossa (+/- PLN) SCIMITAR clinicaltrials.gov/ct2/show/NCT03… out now in the Red Journal @ASTRO_orgQuality-of-Life Outcomes and Toxicity Profile Among Patients with Localized Prostate Cancer After Radical Prostatec… pubmed.ncbi.nlm.nih.gov/36007724/
- Thank you! Special shoutout to early career support from @UCLAJCCC @ASTRO_org @PCFnews. Looking forward to optimizing radiation for prostate cancer with @CDMRP !Proud to share that #uclaradonc Dr. @AmarUKishan has received a $1.1 million grant from the Dept. of Defense to help improve radiation treatment of prostate cancer. Join me in congratulating Dr. Kishan on this win. ucla.in/33fNoz8 @UCLAHealth @UCLAJCCC @dgsomucla
